Early weight loss responders to liraglutide 3.0mg had greater weight loss, regression to normoglycaemia, and reduced Type 2 diabetes development at three years vs early non-responders: SCALE Obesity and Prediabetes



Le Roux, CW, Lau, DCW, Fujioka, K, Greenway, F, Wilding, JPH ORCID: 0000-0003-2839-8404, Jacobsen, PB, Skjoth, T and Madsbad, S
(2017) Early weight loss responders to liraglutide 3.0mg had greater weight loss, regression to normoglycaemia, and reduced Type 2 diabetes development at three years vs early non-responders: SCALE Obesity and Prediabetes. .

[img] Text
M:\Word\Clinical Trials\NOVO\SCALE OBESITY\Le Roux DUK abstract 2017 Early weight loss responders to liraglutide 3.docx - Accepted Version

Download (13kB)
Item Type: Conference or Workshop Item (Unspecified)
Depositing User: Symplectic Admin
Date Deposited: 15 Nov 2017 16:16
Last Modified: 02 Sep 2021 12:10
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3010966